In AMD, TGF-β1 remained elevated after anti-vascular endothelial growth factor (VEGF) treatment, suggesting the regulation of TGF-β1 signaling was VEGF-independent [20]. This evidence concerns the gene TGFB1 and age-related macular degeneration.